// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

A MOBILE APP FOR THE SELF-MANAGEMENT OF TYPE 1 DIABETES AMONG ADOLESCENTS: LESSONS LEARNED FROM A RANDOMIZED CONTROLLED TRIAL

Palmert M - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

THE BRIGHT RANDOMISED STUDY: SIMILAR GLYCAEMIC CONTROL AND LESS CONFIRMED HYPOGLYCAEMIA WITH GLA-300 VS IDEG-100 DURING THE INITIAL TITRATION PERIOD

Ritzel R - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Insulin glargine

IMPACT OF GLUCOSE ANALYTIC ERROR ON RISK OF MISCLASSIFICATION OF PATIENTS USING AMERICAN DIABETES ASSOCIATION DIAGNOSTIC CRITERIA

Lyon O - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

IMPACT OF HBA1C ANALYTIC ERROR ON CLASSIFICATION OF PATIENTS USING AMERICAN DIABETES ASSOCIATION DIAGNOSTIC CRITERIA

Lyon O - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

A PILOT NON-INFERIORITY RANDOMIZED CONTROLLED TRIAL TO ASSESS AUTOMATIC ADJUSTMENTS OF INSULIN DOSES FOR PATIENTS WITH TYPE 1 DIABETES ON MULTIPLE DAILY INJECTIONS THERAPY

El Fathi A - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

ESTIMATION OF NHS SAVINGS THROUGH THE INTRODUCTION OF REAL-TIME CONTINUOUS GLUCOSE MONITORING FOR PREGNANT WOMEN WITH TYPE 1 DIABETES

Murphy H - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Type 1 diabetes mellitus

N/A

GAMIFICATION FOR THE SELF-MANAGEMENT OF DIABETES

Dyal N - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

USER EXPERIENCE WITH A NEW SMARTPHONE APPLICATION FOR BLOOD GLUCOSE MONITORING (BGM) IN AN INFORMATION-MOTIVATION-BEHAVIORAL SKILLS (IMB) MODEL STUDY

Fisher W - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

160 FitViz-Ad: A Non-Intrusive Reminder to Support and Encourage Rheumatoid Arthritis Patients with Physical Activity

Xin Tong - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

159 Promoting Physical Activity and Movement for Arthritis Patients through a Virtual Reality Game

Xin Tong - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

156 The association of sarcopenia with low back pain and lumbar spine degeneration

Yu Jin Seo - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Sarcopenia

N/A

75 Breaking barriers to care: learnings from Pain BC’s Pain Support Line

Mark Nazemi - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

N/A

30 A Randomized, Controlled, Crossover Study to Assess the Abuse Potential of Lasmiditan

Darren Wilbraham - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alprazolam

25 ‘I’ve Got the Power!’ People in Pain and their Journey through Coaching

Mark Nazemi - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

24 The Design and Evaluation of AS IF for Sharing Chronic Pain Patients’ Experience in Virtual Reality Settings

Xin Tong, Pegah Kiaei - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

N/A

23 Does Immersive Virtual Reality Provide Modulate Chronic Pain: A Longitudinal Study Design

Ruoyu Li - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Chronic pain

N/A

22 A Serious Immersive Virtual Reality Game for Promoting Chronic Arthritis Pain Patients’ General Physical Activity and Range of Motion

Xin Tong - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

11 The Burden of Pain Symptoms: A prototype for citizens of British Columbia

Bhairavi Warke - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Chronic pain

N/A

1 Expert Consensus on the Optimization of Cannabinoids and Opioids for Chronic Pain Control

Aaron Sihota - Pain Week Conference , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Chronic pain

N/A

Can a bone protein protect against muscular dystrophy?

Jerome Frenette - European Congress of Endocrinology (ECE) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

OPG-Fc

Copyright © 2026. QuantiNova All rights reserved